All Stories

  1. Utilizing Clinical Pharmacy Specialists to Address Access to Care Barriers in the Veteran Population for the Management of Diabetes
  2. Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes
  3. Assessment and Revision of Clinical Pharmacy Practice Internet Web Sites
  4. Statins in the treatment of asthma
  5. Race as a Factor for Intensification of Diabetes Medications
  6. An Update in Incretin-Based Therapy: A Focus on Glucagon-Like Peptide-1 Receptor Agonists
  7. An Update in Incretin-Based Therapy: A Focus on Dipeptidyl Peptidase - 4 Inhibitors
  8. Ranolazine for the treatment of refractory angina in a veterans population
  9. Effects of Combined Use of Antiretroviral Agents and Atypical Antipsychotics on Lipid Parameters
  10. Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy
  11. Combination thiazolidinedione and fibrate effect on high-density lipoprotein cholesterol (HDL-C) concentration in a Veterans Affairs patient population
  12. Third-Line Agent Selection for Patients with Type 2 Diabetes Mellitus Uncontrolled with Sulfonylureas and Metformin
  13. A retrospective study of the lipid-lowering efficacy and safety of ezetimibe added to hydroxy methylglutaryl coenzyme A reductase therapy in HIV-infected patients with hyperlipidemia
  14. Evaluation of thiazide diuretic use as preferred therapy in uncomplicated essential hypertension patients
  15. Gatifloxacin-Induced Hyperglycemia: A Review of 4 Cases and the Literature
  16. Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers on the Rate of New-Onset Diabetes Mellitus: A Review and Pooled Analysis
  17. Implications of Rosiglitazone and Pioglitazone on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus
  18. New onset diabetes and atypical antipsychotics